Tag: Developed

Core outcome sets (COS), important outcomes that should be measured in clinical trials, are largely absent in atopic dermatitis (AD) research. This prevents the combining of evidence from systematic reviews of important therapeutic interventions for AD, leading to a lack of unbiased evidence to guide clinical practice. The international Harmonising Outcome Measures for Eczema (HOME), […]